Thursday, June 4, 2020

Neal D. Shore, MD, FACS Discusses Impact, Treatment Implications of the Phase III HERO Trial | Cancer Network

Neal D. Shore, MD, FACS Discusses Impact, Treatment Implications of the Phase III HERO Trial | Cancer Network: The Carolina Urologic Research Center expert discusses the benefits of oral relugolix for patients with prostate cancer.

No comments:

Post a Comment